We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ablynx, Merck & Co. Expand Immuno-Oncology Collaboration

News   Jul 23, 2015

 
Ablynx, Merck & Co. Expand Immuno-Oncology Collaboration
 
 
 

RELATED ARTICLES

Let the Rabbit See the Virus

News

Researchers have validated the role of specific rabbit genes in contributing to their resistance to the myxoma virus which once ravaged rabbit populations.

READ MORE

Reversing Memory Loss Linked to Depression and Aging

News

New therapeutic molecules developed at Toronto’s Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging.

READ MORE

Animal Venoms Aid the Search for New Medicines

News

Animal venoms are the subject of study at research center based at the Butantan Institute in São Paulo. But in this case, the idea is not to find antidotes, but rather to use the properties of the venoms themselves to identify molecular targets of diseases and, armed with that knowledge, develop new compounds that can be used as medicines.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE